MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ebiom.2026.106212

Медицинская библиотека · EBioMedicine · 2026

Long-term impact of SARS-CoV-2 on recurrent COPD exacerbations.

Henry Sonya S, Duong Kevin E, Duong Tim Q

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

SARS-CoV-2 infection could increase the long-term risk of recurrent chronic obstructive pulmonary disease (COPD) exacerbations. This study investigated the long-term risk of COPD exacerbations following SARS-CoV-2 infection, with comparisons by hospitalisation status.

METHODS

We conducted a retrospective cohort study using data from a large urban academic health system (March 2020-February 2025). The final cohort comprised of 2268 hospitalised and 1471 non-hospitalised COVID-19 patients with pre-existing COPD, each matched 1:1 by propensity score with non-COVID controls. Adjusted hazard ratios (aHRs) were estimated using Andersen-Gill models, and adjusted incidence rate ratios (aIRRs) using negative binomial models. Cumulative hazards were derived from Nelson-Aalen curves. Secondary analyses evaluated socioeconomic factors and multiple sensitivity analyses assessed robustness.

FINDINGS: Among hospitalised patients, the incidence rate of COPD exacerbations was 35.7 per 100 person-years in the COVID-19 cohort, compared to 15.9 in controls (aIRR 1.81 [95% CI, 1.45-2.26]). Among non-hospitalised patients, rates were 13.7 vs 10.6 (aIRR 1.23 [0.88-1.73]). Hospitalised patients had a higher overall hazard of recurrent COPD exacerbations (aHR 1.69 [1.36-2.10]; p < 0.001), with risk persisting over four years post-infection. No significant difference was observed among non-hospitalised patients. Unmet social needs increased the risk by 53% among hospitalised patients, while Medicaid or Medicare coverage more than doubled the risk among non-hospitalised patients relative to private insurance. Findings were consistent across multiple sensitivity analyses.

INTERPRETATION: COVID-19 hospitalisation was associated with a sustained increased risk of recurrent COPD exacerbations, underscoring the need for long-term pulmonary follow-up and targeted interventions in this high-risk population.

FUNDING: None.

Для цитирования: Henry Sonya S, Duong Kevin E, Duong Tim Q. Long-term impact of SARS-CoV-2 on recurrent COPD exacerbations.. EBioMedicine. 2026. DOI: 10.1016/j.ebiom.2026.106212.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.